Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Автор: | Tamanna, Mst. Taskia |
---|---|
Інші автори: | Sharmin, Dr. Sabrina |
Формат: | Дисертація |
Мова: | English |
Опубліковано: |
Brac University
2023
|
Предмети: | |
Онлайн доступ: | http://hdl.handle.net/10361/18146 |
Схожі ресурси
-
Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
за авторством: Hassan, Md. Muhtaz
Опубліковано: (2020) -
Role of protein’s and future treatment options for Alzheimer’s Disease
за авторством: Islam, Md. Irfath
Опубліковано: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
за авторством: Alim, Abdul
Опубліковано: (2023) -
Marine compounds in the treatment of Alzheimer’s disease
за авторством: Parveen, Sanjana
Опубліковано: (2022) -
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
за авторством: Tabassum, Nadira
Опубліковано: (2024)